The effect of insulin on the alpha cell response to hyperglycemia in long standing alloxan diabetes

J. T. Braaten, G. R. Faloona, Roger H Unger

Research output: Contribution to journalArticle

59 Citations (Scopus)

Abstract

In acute experimental diabetes in animals, alpha cell unresponsiveness to hyperglycemia can be promptly corrected by insulin, but in human diabetes, even massive doses of insulin have little effect. To determine if this inability of insulin to correct the alpha cell abnormality in man is merely the consequence of the long duration of the diabetic state (rather than of a difference in mechanism), the effect of insulin was studied in alloxan diabetes of long duration. Alloxan diabetic dogs were maintained for 7 to 18 mth and treated daily with insulin. When glucose was infused without insulin, glucagon did not decline but rose paradoxically. However, when insulin was infused at a rate of 9 mU/kg/min together with glucose, a prompt decline in glucagon from a base line average of 171 pg/ml SEM ± 34 to a nadir of 41 pg/ml SEM ± 9 was observed. This decline indicated that alpha cell responsiveness to hyperglycemia is completely restored by large quantities of insulin. To determine if small amounts of insulin would similarly restore alpha cell responsiveness in long standing experimental diabetes, 1.4 mU/kg/min was infused. By the time the mean insulin level had risen 43 μU/ml, glucagon had declined significantly and ultimately fell to a nadir of 44 pg/ml. It is concluded from these studies that alpha cell responsiveness to hyperglycemia can be fully restored in long standing alloxan diabetic dogs as readily as in acutely diabetic dogs. Its ineffectiveness in restoring alpha cell responsiveness to hyperglycemia in human diabetes may not, therefore, be related to duration of the diabetic state, and may reflect a primary alpha cell defect.

Original languageEnglish (US)
Pages (from-to)1017-1021
Number of pages5
JournalJournal of Clinical Investigation
Volume53
Issue number4
StatePublished - 1974

Fingerprint

Experimental Diabetes Mellitus
Hyperglycemia
Insulin
Glucagon
Alloxan
Dogs
Glucose

ASJC Scopus subject areas

  • Medicine(all)

Cite this

The effect of insulin on the alpha cell response to hyperglycemia in long standing alloxan diabetes. / Braaten, J. T.; Faloona, G. R.; Unger, Roger H.

In: Journal of Clinical Investigation, Vol. 53, No. 4, 1974, p. 1017-1021.

Research output: Contribution to journalArticle

@article{22e1d0d2e0bc410db44ef1e5bd68ca16,
title = "The effect of insulin on the alpha cell response to hyperglycemia in long standing alloxan diabetes",
abstract = "In acute experimental diabetes in animals, alpha cell unresponsiveness to hyperglycemia can be promptly corrected by insulin, but in human diabetes, even massive doses of insulin have little effect. To determine if this inability of insulin to correct the alpha cell abnormality in man is merely the consequence of the long duration of the diabetic state (rather than of a difference in mechanism), the effect of insulin was studied in alloxan diabetes of long duration. Alloxan diabetic dogs were maintained for 7 to 18 mth and treated daily with insulin. When glucose was infused without insulin, glucagon did not decline but rose paradoxically. However, when insulin was infused at a rate of 9 mU/kg/min together with glucose, a prompt decline in glucagon from a base line average of 171 pg/ml SEM ± 34 to a nadir of 41 pg/ml SEM ± 9 was observed. This decline indicated that alpha cell responsiveness to hyperglycemia is completely restored by large quantities of insulin. To determine if small amounts of insulin would similarly restore alpha cell responsiveness in long standing experimental diabetes, 1.4 mU/kg/min was infused. By the time the mean insulin level had risen 43 μU/ml, glucagon had declined significantly and ultimately fell to a nadir of 44 pg/ml. It is concluded from these studies that alpha cell responsiveness to hyperglycemia can be fully restored in long standing alloxan diabetic dogs as readily as in acutely diabetic dogs. Its ineffectiveness in restoring alpha cell responsiveness to hyperglycemia in human diabetes may not, therefore, be related to duration of the diabetic state, and may reflect a primary alpha cell defect.",
author = "Braaten, {J. T.} and Faloona, {G. R.} and Unger, {Roger H}",
year = "1974",
language = "English (US)",
volume = "53",
pages = "1017--1021",
journal = "Journal of Clinical Investigation",
issn = "0021-9738",
publisher = "The American Society for Clinical Investigation",
number = "4",

}

TY - JOUR

T1 - The effect of insulin on the alpha cell response to hyperglycemia in long standing alloxan diabetes

AU - Braaten, J. T.

AU - Faloona, G. R.

AU - Unger, Roger H

PY - 1974

Y1 - 1974

N2 - In acute experimental diabetes in animals, alpha cell unresponsiveness to hyperglycemia can be promptly corrected by insulin, but in human diabetes, even massive doses of insulin have little effect. To determine if this inability of insulin to correct the alpha cell abnormality in man is merely the consequence of the long duration of the diabetic state (rather than of a difference in mechanism), the effect of insulin was studied in alloxan diabetes of long duration. Alloxan diabetic dogs were maintained for 7 to 18 mth and treated daily with insulin. When glucose was infused without insulin, glucagon did not decline but rose paradoxically. However, when insulin was infused at a rate of 9 mU/kg/min together with glucose, a prompt decline in glucagon from a base line average of 171 pg/ml SEM ± 34 to a nadir of 41 pg/ml SEM ± 9 was observed. This decline indicated that alpha cell responsiveness to hyperglycemia is completely restored by large quantities of insulin. To determine if small amounts of insulin would similarly restore alpha cell responsiveness in long standing experimental diabetes, 1.4 mU/kg/min was infused. By the time the mean insulin level had risen 43 μU/ml, glucagon had declined significantly and ultimately fell to a nadir of 44 pg/ml. It is concluded from these studies that alpha cell responsiveness to hyperglycemia can be fully restored in long standing alloxan diabetic dogs as readily as in acutely diabetic dogs. Its ineffectiveness in restoring alpha cell responsiveness to hyperglycemia in human diabetes may not, therefore, be related to duration of the diabetic state, and may reflect a primary alpha cell defect.

AB - In acute experimental diabetes in animals, alpha cell unresponsiveness to hyperglycemia can be promptly corrected by insulin, but in human diabetes, even massive doses of insulin have little effect. To determine if this inability of insulin to correct the alpha cell abnormality in man is merely the consequence of the long duration of the diabetic state (rather than of a difference in mechanism), the effect of insulin was studied in alloxan diabetes of long duration. Alloxan diabetic dogs were maintained for 7 to 18 mth and treated daily with insulin. When glucose was infused without insulin, glucagon did not decline but rose paradoxically. However, when insulin was infused at a rate of 9 mU/kg/min together with glucose, a prompt decline in glucagon from a base line average of 171 pg/ml SEM ± 34 to a nadir of 41 pg/ml SEM ± 9 was observed. This decline indicated that alpha cell responsiveness to hyperglycemia is completely restored by large quantities of insulin. To determine if small amounts of insulin would similarly restore alpha cell responsiveness in long standing experimental diabetes, 1.4 mU/kg/min was infused. By the time the mean insulin level had risen 43 μU/ml, glucagon had declined significantly and ultimately fell to a nadir of 44 pg/ml. It is concluded from these studies that alpha cell responsiveness to hyperglycemia can be fully restored in long standing alloxan diabetic dogs as readily as in acutely diabetic dogs. Its ineffectiveness in restoring alpha cell responsiveness to hyperglycemia in human diabetes may not, therefore, be related to duration of the diabetic state, and may reflect a primary alpha cell defect.

UR - http://www.scopus.com/inward/record.url?scp=0015966626&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0015966626&partnerID=8YFLogxK

M3 - Article

C2 - 4592597

AN - SCOPUS:0015966626

VL - 53

SP - 1017

EP - 1021

JO - Journal of Clinical Investigation

JF - Journal of Clinical Investigation

SN - 0021-9738

IS - 4

ER -